ArticleJournal of environmental economics and management2021
Habitat loss and the risk of disease outbreak.
Article in Journal of environmental economics and management, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 40 citations in OpenAlex.
- Wet markets, live animals, and infection concerns in Thailand: A cross-sectional study.One health (Amsterdam, Netherlands) · 2026Article
- Integrating explainable AI and One Health: a new frontier in combating infectious diseases.EBioMedicine · 2026Article
- Development of X-SIAGA: A disease X and outbreak preparedness intervention for indigenous households in Selangor, Malaysia.PloS one · 2026Article
- Climate differentially impacts ticks infected and uninfected withScience advances · 2025Article
- Poverty-disease-environment traps: Locally tailored solutions and collective action.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- Modeling how and why aquatic vegetation removal can free rural households from poverty-disease traps.Proceedings of the National Academy of Sciences of the United States of America · 2024Article
- Pandemic-Proofing: Intercepting Zoonotic Spillover Events.Pathogens (Basel, Switzerland) · 2024Review
- Intersecting realities: Exploring the nexus between armed conflicts in eastern Democratic Republic of the Congo and Global Health.One health (Amsterdam, Netherlands) · 2024Article
- One World, One Health: Zoonotic Diseases, Parasitic Diseases, and Infectious Diseases.Healthcare (Basel, Switzerland) · 2024Article
- Spatio-temporal variability in transmission risk of human schistosomes and animal trematodes in a seasonally desiccating East African landscape.Proceedings. Biological sciences · 2024Article
- Snail juvenile growth rate as a rapid predictor of the transmission potential of parasitizing human schistosomes.Experimental parasitology · 2022Article
- Human Respiratory Infections in Nigeria: Influenza and the Emergence of SARS-CoV-2 Pandemic.Vaccines · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Evidence suggests that emerging infectious diseases, such as COVID-19, originate from wildlife species, and that land-use change is an important pathway for pathogen transmission to humans. We first focus on zoonotic disease spillover and the rate at which primary human cases appear, demonstrating that a potential outbreak is directly related to the area of wildlife habitat. We then develop a model of the costs and benefits of land conversion that includes the effect of habitat size on the risk of disease outbreak. Our model and numerical simulations show that incorporating this risk requires more wildlife habitat conservation in the long run, and how much more should be conserved will depend on the initial habitat size. If the area is too small, then no conversion should take place. Any policy to control habitat loss, such as a tax imposed on the rents from converted land, should also vary with habitat area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.